Advertisement
News
Advertisement

NormOxys appoints Riedel to lead regulatory affairs

Tue, 10/05/2010 - 10:33am
Mass High Tech: The Journal of New England Technology

Gerard (Rod) Riedel has been named vice president, regulatory affairs and program management, at Wellesley biotech NormOxys Inc.

In his new role, Riedel will be responsible for leading the company’s drug development and working with national health authorities and regulatory agencies. Specifically, he will help advance NormOxys’ lead drug candidate, OXY111A, which is being tested in clinical studies to treat cancer and cardiovascular diseases.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading